UPDATE 2-Teva, Allergan win U.S. antitrust approval for generics deal

WASHINGTON, July 27 (Reuters) - Teva Pharmaceutical

Industries Ltd won U.S. antitrust approval to purchase

Allergan Plc's generics business, after agreeing to

divest 79 generic drugs to rival firms, the Federal Trade

Commission said on Wednesday.

Read more